Agiloak Innovates

We specialize in Health and Social Care Innovation – never forgetting that people come first.

Winners of the 2017 Terry Feest Award for Innovation from the UK Renal Registry.


At the beginning of this year, Agiloak LLC agreed to become the USA distributor for BenignEye – An Intelligent home monitoring system.

BenignEye is a system which allows elderly, vulnerable people living alone to stay independent for much longer in support of the Aging in Place movement. It is an unobtrusive, simple to use system which monitors daily activities through home automation sensors. It then uses machine learning to find anomalies in the behavior pattern of the elderly person, and report those anomalies to a family member or other carer.

So if Granny has not been up and about by 9am, when she is normally up at 7am, then you will get a notification. Or you can look at a chart of movements to see that Grandad was up several times in the night.

This provides Independence and Peace of Mind in a very cost-effective manner.

BenignEye is in numerous pilot sites in the UK at the moment and will go on general sale in a couple of months. Here in the USA we have one pilot site and are looking to commission up to 10 more to gain real-life experience before going to general availability.

Visit Benigneye.Agiloak.Com for more information


KBudd is a revolutionary new Mobile application which will improve Medication Adherence in adolescent and young adult Kidney Transplant patients.

All transplant patients are at risk of organ rejection if they do not take a combination of strong immunosuppressant drugs according to a strict timetable. Failure to comply with the schedule allows the body’s own immune system to gain strength and attack the organ. There are a number of reasons why young patients (13-21) are at greatest risk from this.

KBudd uses a powerful combination of social media, artificial intelligence,  gamification and behavior change techniques to measure and improve patient engagement.

Improved patient engagement has been clearly demonstrated to lead to a range of better outcomes including their adherence to Medication regimes.

We are currently building the team to make this transformative project happen.

Watch this space – or get in touch if you believe you can help.


Benign Eye

Agiloak LLC are pleased to announce that we have entered into partnership with BenignEye.Com from the United Kingdom and are the sole North American distributor for the B9Eye Intelligent Monitoring System.

UK Renal Registry

Agiloak have been working with the UK Renal Registry for a number of years and in 2017 our founder, Nick Jones, was awarded the 2017 Terry Feest award for Innovation by the UKRR.